Resultados da busca - Ido Wolf
- Mostrando 1 - 20 resultados de 22
- Ir para a próxima página
-
1
Breaking Bad News via Telemedicine: A New Challenge at Times of an Epidemic por Ido Wolf, Barliz Waissengrin, Sharon Pelles
Publicado em 2020Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
Head-to-head comparison of [68Ga]Ga-FAPI-04 and [18F]-FDG PET/CT in evaluating the extent of disease in gastric adenocarcinoma por Jonathan Kuten, Charles Levine, Ofer Shamni, Sharon Pelles, Ido Wolf, Guy Lahat, Eyal Mishani, Einat Even‐Sapir
Publicado em 2021Artigo -
9
-
10
-
11
Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest por Ido Wolf, James O’Kelly, Naoki Wakimoto, Anh Duy Nguyen, Franck Amblard, Beth Y. Karlan, Jack L. Arbiser, H. Phillip Koeffler
Publicado em 2007Artigo -
12
Rapid Implementation of Telemedicine During the COVID-19 Pandemic: Perspectives and Preferences of Patients with Cancer por Shira Peleg Hasson, Barliz Waissengrin, Eliya Shachar, Marah Hodruj, Rochelle A. Fayngor, Mirika Brezis, Alla Nikolaevski‐Berlin, Sharon Pelles, Tamar Safra, Ravit Geva, Ido Wolf
Publicado em 2021Artigo -
13
Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer por Hagai Ligumsky, Herut Dor, Tal Etan, Inbal Golomb, Alla Nikolaevski‐Berlin, Inbal Greenberg, Tamar Halperin, Yoel Angel, Oryan Henig, Avishay Spitzer, Marina Slobodkin, Ido Wolf
Publicado em 2021Artigo -
14
Immunogenicity and Safety of the BNT162b2 mRNA COVID-19 Vaccine Among Actively Treated Cancer Patients por Hagai Ligumsky, Esraa Safadi, Tal Etan, Noam Vaknin, Manuel Waller, Assaf Croll, Alla Nikolaevski‐Berlin, Inbal Greenberg, Tami Halperin, Asaf Wasserman, Lior Galazan, Nadir Arber, Ido Wolf
Publicado em 2021Artigo -
15
Abdominal Desmoid: Course, Severe Outcomes, and Unique Genetic Background in a Large Local Series por Ophir, Gilad, Sivan, Shamai, Hana, Strul, Guy, Rosner, Nathan, Gluck, Naomi, Fliss Isakov, Joseph, Klausner, Ido, Wolf, Ofer, Merimsky, Yael, Goldberg, Zohar, Levi, Alona, Zer, Revital, Kariv
Publicado em 2021Texto -
16
Sodium-glucose co-transporter-2 inhibitors in patients treated with immune checkpoint inhibitors por Moran Gvili Perelman, Rafael Y. Brzezinski, Barliz Waissengrin, Yasmin Leshem, Or Bainhoren, Tammi Rubinstein, Maxim Perelman, Zach Rozenbaum, Ofer Havakuk, Yan Topilsky, Shmuel Banai, Ido Wolf, Michal Laufer‐Perl
Publicado em 2024Artigo -
17
D538G Mutation in Estrogen Receptor-α: A Novel Mechanism for Acquired Endocrine Resistance in Breast Cancer por Keren Merenbakh-Lamin, Noa Ben-Baruch, Adva Yeheskel, Addie Dvir, Lior Soussan‐Gutman, Rinath Jeselsohn, Roman Yelensky, Myles Brown, Vincent A. Miller, David Sarid, Shulamith Rizel, Baruch Klein, Tamar Rubinek, Ido Wolf
Publicado em 2013Artigo -
18
Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis por Omer Goldman, Lital N. Adler, Emma Hajaj, Tommaso Croese, Naama Darzi, Sivan Galai, Hila Tishler, Yarden Ariav, Dor Lavie, Liat Fellus-Alyagor, Roni Oren, Yuri Kuznetsov, Eyal David, Rami Jaschek, Chani Stossel, Oded Singer, Sergey Malitsky, Renana Barak, Rony Seger, Neta Erez, Ido Amit, Amos Tanay, Ann Saada, Talia Golan, Tamar Rubinek, Joo Sang Lee, Shay Ben‐Shachar, Ido Wolf, Ayelet Erez
Publicado em 2023Artigo -
19
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy... por Guy A. Van Hazel, Volker Heinemann, Navesh Sharma, Michael Findlay, Jens Ricke, Marc Peeters, D Díaz Pérez, Bridget A. Robinson, Andrew Strickland, Tom Ferguson, Javier Rodríguez, H. Kröning, Ido Wolf, Vinod Ganju, Euan Walpole, Éveline Boucher, Thomas Tichler, Einat Shacham‐Shmueli, Alex Powell, Paul Eliadis, Richard Isaacs, David Price, Fred M Moeslein, Julien Taı̈eb, G. Bower, Val Gebski, Mark Van Buskirk, David Cade, Kenneth G. Thurston, Peter Gibbs
Publicado em 2016Artigo -
20
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor–Positive Breast Cancer por Rinath Jeselsohn, Roman Yelensky, Gilles Buchwalter, Garrett M. Frampton, Funda Meric‐Bernstam, Ana M. González-Angulo, Jaime Ferrer-Lozano, José Alejandro Pérez Fidalgo, Massimo Cristofanilli, Henry Gómez, Carlos L. Arteaga, Jennifer M. Giltnane, Justin M. Balko, Maureen Cronin, Mirna Jarosz, James Sun, Matthew Hawryluk, Doron Lipson, Geoff Otto, Jeffrey S. Ross, Addie Dvir, Lior Soussan‐Gutman, Ido Wolf, Tamar Rubinek, Lauren Gilmore, Stuart J. Schnitt, Steven E. Come, Lajos Pusztai, Philip Stephens, Myles Brown, Vincent A. Miller
Publicado em 2014Artigo
Ferramentas de busca:
Assuntos relacionados
Medicine
Internal medicine
Cancer
Cancer research
Biology
Disease
Coronavirus disease 2019 (COVID-19)
Infectious disease (medical specialty)
Breast cancer
Chemotherapy
Oncology
Endocrinology
Estrogen receptor
Immune system
Immunology
Physics
Receptor
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
2019-20 coronavirus outbreak
Biochemistry
Cell biology
Confidence interval
Genetics
Hazard ratio
Outbreak
Virology
Carcinogenesis
Clinical endpoint
Clinical trial
Colorectal cancer